COVID-19
Regístrese
Enfermedades Infecciosas y Microbiología Clínica
Suscribe to the journal
Buscar en
Enfermedades Infecciosas y Microbiología Clínica
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica Evolution of antibiotic multiresistance in Escherichia coli and Klebsiella pneum...
Journal Information
Back to article

Statistics

Follow this link to access the full text of the article

Original article
Evolution of antibiotic multiresistance in Escherichia coli and Klebsiella pneumoniae isolates from urinary tract infections: A 12-year analysis (2003–2014)
Evolución de la multirresistencia a los antibióticos en Escherichia coli y Klebsiella pneumoniae aislados de infecciones del tracto urinario. Un análisis de 12 años (2003-2014)
David M. Aranaa, Margarita Rubiob, Juan-Ignacio Alósa,b,
Corresponding author
nachoalos@telefonica.net

Corresponding author.
a Servicio de Microbiología, Hospital Universitario de Getafe, Getafe, Madrid, Spain
b Facultad de Ciencias Biomédicas, Universidad Europea de Madrid, Villaviciosa de Odón, Madrid, Spain
Read
6852
Times
was read the article
2652
Total PDF
4200
Total HTML
Share statistics
Article information
ISSN: 0213005X
Original language: English
DOI:10.1016/j.eimc.2016.02.018
The statistics are updated each day
Year/Month Html Pdf Total
2024 April 21 16 37
2024 March 32 20 52
2024 February 31 7 38
2024 January 36 11 47
2023 December 40 31 71
2023 November 33 11 44
2023 October 32 45 77
2023 September 30 18 48
2023 August 22 38 60
2023 July 16 34 50
2023 June 35 43 78
2023 May 55 7 62
2023 April 48 13 61
2023 March 29 13 42
2023 February 22 7 29
2023 January 29 16 45
2022 December 29 15 44
2022 November 42 28 70
2022 October 44 22 66
2022 September 31 13 44
2022 August 50 36 86
2022 July 40 14 54
2022 June 54 26 80
2022 May 56 24 80
2022 April 62 38 100
2022 March 82 26 108
2022 February 97 27 124
2022 January 84 12 96
2021 December 55 28 83
2021 November 61 19 80
2021 October 102 24 126
2021 September 52 38 90
2021 August 60 22 82
2021 July 58 16 74
2021 June 44 29 73
2021 May 64 12 76
2021 April 122 47 169
2021 March 88 30 118
2021 February 73 24 97
2021 January 63 30 93
2020 December 57 25 82
2020 November 46 26 72
2020 October 47 21 68
2020 September 63 24 87
2020 August 50 35 85
2020 July 39 16 55
2020 June 33 18 51
2020 May 51 32 83
2020 April 46 20 66
2020 March 41 18 59
2020 February 72 44 116
2020 January 90 40 130
2019 December 77 30 107
2019 November 53 34 87
2019 October 70 30 100
2019 September 49 27 76
2019 August 46 20 66
2019 July 23 39 62
2019 June 41 44 85
2019 May 101 153 254
2019 April 45 91 136
2019 March 22 23 45
2019 February 24 27 51
2019 January 21 11 32
2018 December 22 22 44
2018 November 37 12 49
2018 October 37 25 62
2018 September 44 12 56
2018 August 26 17 43
2018 July 21 18 39
2018 June 19 7 26
2018 May 441 12 453
2018 April 64 20 84
2018 March 16 6 22
2018 February 16 7 23
2018 January 25 1 26
2017 December 16 9 25
2017 November 25 12 37
2017 October 27 0 27
2017 September 5 1 6
2017 August 2 0 2
2017 July 4 0 4
2017 June 12 6 18
2017 May 82 83 165
2017 March 0 2 2
2017 February 2 11 13
2017 January 0 8 8
2016 December 2 12 14
2016 November 3 512 515
2016 October 7 23 30
2016 September 7 14 21
2016 August 6 16 22
2016 July 1 6 7
Show all

Follow this link to access the full text of the article

Subscribe to our newsletter

Publish in
Enfermedades Infecciosas y Microbiología Clínica
Special content about COVID-19
Free access articles
Executive summary of the consensus document on the shared...
Enferm Infecc Microbiol Clin. 2024;42:102-7
Executive Summary of the Consensus Statement of the Spanish...
Enferm Infecc Microbiol Clin. 2020;38:283-8
SARS-CoV-2 infection as trigger multisystem inflammatory...
Enferm Infecc Microbiol Clin. 2021;39:262-4


La Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica agradece la colaboración de:

SOCIOS PROTECTORES

    - Pfizer GEP, S.L.U.
    - Shionogi, S.L.U.
    - AbbVie Spain, S.L.U.
    - Gilead Sciences, S.L.U.
    - Vircell Spain, S.L.U.
    - Roche Diagnostics, S.L.U.
    - ASTRAZENECA FARMACÉUTICA SPAIN, S.A.
    - Qiagen Iberia S.L.
    - Laboratorios ViiV Healthcare, S.L.

SOCIOS PATROCINADORES

- Becton Dickinson S.A.U.
- Janssen-Cilag, S.A.
- Angelini Farmacéutica, S.A.
- Biomerieux España, S,A.U.
- Merck Sharp & Dohme de España, S.A.
- Hologic Iberia, S.L.U.
- Laboratorios Menarini S.A.
- Accelerate Diagnostics S.L.
- Abbott Laboratories, S.A.
- Cepheid Iberia S.L.U.
- Illumina Productos de España. S.L.U.
- DiaSorin Iberia, S.A.
- GlaxoSmithKline, S.A.
- Sysmex España S.L.

Enfermedades Infecciosas y Microbiología Clínica follows the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos